Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,001–2,100 of 3,349
Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology
Dansokho, C., Aucouturier, P., & Dorothée, G. (2017) · Brain · doi:10.1093/brain/awx108 · Cited by 9
Endophilin 1 knockdown prevents synaptic dysfunction induced by oligomeric amyloid β
Yin, Y., Cha, C., Wu, F., Li, J., Li, S., Zhu, X., Zhang, J., & Guo, G. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10158 · Cited by 11
Self-citationKaur, G., Poljak, A., Braidy, N., Crawford, J. D., Lo, J., & Sachdev, P. S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200052 · Cited by 11
Rushing, B., Rohlik, D., Roy, S., Skaff, D., & Garcia, B. (2020) · Molecules · doi:10.3390/molecules25174016 · Cited by 9
“The classical pathway has also been shown to play causal roles in mouse models of Alzheimer’s disease [12] and has been genetically linked to other neurological disorders, such as schizophrenia [25].”
BackgroundGround state depletion microscopy as a tool for studying microglia–synapse interactions
Paasila, P. J., Fok, S., Rodriguez, N. F., Sajjan, S., Svahn, A. J., Dennis, C. V., Holsinger, R. M. D., Kril, J. J., Becker, T. S., Banati, R. B., et al. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24819 · Cited by 8
Liang, Y., Lee, D. Y. W., Zhen, S. Y., Sun, H., Zhu, B., Liu, J., Lei, D., Lin, C., Zhang, S., Jacques, N. A., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154158 · Cited by 13
Linzey, M. R., DiSano, K. D., Welsh, N. C., Pachner, A. R., & Gilli, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.924734 · Cited by 10
“Complement activation can also induce microgliosis and astrogliosis in neuroinflammatory conditions and aid in the recruitment of peripheral immune cells in the CNS (22, 23).”
BackgroundQiao, N., Zhang, J., Zhang, Y., & Liu, X. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.11.001 · Cited by 9
Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease
Chen, H., Deng, C., Meng, Z., & Meng, S. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2711312 · Cited by 10
“[18] revealed that complement is associated with microglia-mediated early synaptic loss in AD model mouse.”
BackgroundAyoub, I., Dauvilliers, Y. A., Barateau, L., Vermeulen, T., Mouton‐Barbosa, E., Marcellin, M., de Peredo, A. G., Groß, C. C., Saoudi, A., & Liblau, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1108682 · Cited by 11
“In a mouse model of AD, it has been shown that C1q, the initiating protein of the classical complement, is increased and associated with synapses before overt plaque deposition (33).”
de Lima, I. B. Q., Cardozo, P. L., Fahel, J. S., Lacerda, J. P. S., de Miranda, A. S., Teixeira, A. L., & Ribeiro, F. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1283331 · Cited by 6
“Although aberrant synapse pruning was shown to contribute to dementia (8), elimination of dystrophic synapses and dendrites, as well as phagocytosis of extracellular protein aggregates, such as amyloid-b (A b ) (9, 10), is essential for proper brain function.”
CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
Comella-Bolla, A., Valente, T., Miguez, A., Brito, V., Ginés, S., Solà, C., Straccia, M., & Canals, J. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224901 · Cited by 11
“In the post-mortem HD brain, astrocytosis and microgliosis has been observed in caudate and the internal capsule with an increase complement biosynthesis by reactive microglia [10], which has been recently described as an important mechanism for early synaptic loss in Alzheimer’s disease (AD) [11].”
BackgroundChirumbolo, S., & Bjørklund, G. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00141 · Cited by 9
“This should suggest that a possible effect of baicalein may be exerted also on the glia, besides neurons, particularly during the inflammatory response (17).”
Prilutsky, D., Kho, A. T., Feiglin, A., Hammond, T., Stevens, B., & Kohane, I. S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/204412 · Cited by 10
Self-citationCorrection to: Neuroimmune Response in Ischemic Preconditioning
McDonough, A., & Weinstein, J. R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0580-5 · Cited by 9
Microglia perform local protein synthesis at perisynaptic and phagocytic structuresPreprint
Vasek, M. J., Deajon-Jackson, J. D., Liu, Y., Crosby, H. W., Yi, J., & Dougherty, J. D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.13.426577 · Cited by 11
Nazmi, A., Griffin, É. W., Field, R. H., Doyle, S., Hennessy, E., O’Donnell, M., Rehill, A. M., McCarthy, A. W., Healy, D., Doran, M. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.18.427123 · Cited by 10
“…state regulator Sall1 and the increased expression of the previously described priming hub genes Itgax, Clec7a and Axl (Holtman et al., 2015) and C3, C1q, Trem2 and Tyrobp which are strongly associated with neurodegeneration and synaptic loss (Hong et al., 2016; Keren-Shaul et al., 2017).”
BackgroundMicroglial cGAS deletion protects against amyloid-β induced Alzheimer’s disease pathogenesisPreprint
He, S., Li, X., Mittra, N., Bhattacharjee, A., Wang, H., Zhao, S., Liu, F., & Han, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.07.552300 · Cited by 12
“development (61), while microglial synaptic pruning has also been demonstrated to mediate 303 synapse loss in AD (62).”
(2024) · aging and disease · doi:10.14336/ad.2023.0614 · Cited by 9
“In the same context, early hippocampal synaptic loss prior to overt amyloid beta plaque deposition was reported in the J20 transgenic mice, modeling AD, as illustrated by decreased levels of PSD-95 and its co-localization with synaptophysin, [81].”
BackgroundINPP5D/SHIP1 regulates inflammasome activation in human microglia
Chou, V., Fancher, S. B., Pearse, R. V., Lee, H., Lam, M., Seyfried, N. T., Bennett, D. A., De Jager, P. L., Menon, V., & Young-Pearse, T. L. (2023) · doi:10.1101/2023.02.25.530025 · Cited by 8
Hosseinzadeh, S., Afshari, S., Molaei, S., Rezaei, N., & Dadkhah, M. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578206 · Cited by 10
Woo, M. S., Nilsson, J., Therriault, J., Rahmouni, N., Brinkmalm, A., Benedet, A. L., Ashton, N. J., Macedo, A. C., Servaes, S., Wang, Y.-T., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02962-z · Cited by 10
“In accordance, studies in different pre-clinical AD models demonstrated that pro-inflammatory microglia lead to excessive synaptic loss by phagocytosis [17].”
BackgroundResultLiu, J., Xu, Y., Ji, Y., Li, K., Wang, S., Zhao, B., Ruan, J., Foulkes, N. S., Zhang, S., & Zhao, H. (2023) · The Innovation Life · doi:10.59717/j.xinn-life.2023.100037 · Cited by 8
Liu, S., Yan, Z., Peng, Y., Liu, Y., Li, Y., Xu, D., Gong, Y., Cui, Z., Wu, Y., Zhang, Y., et al. (2023) · Parasites & Vectors · doi:10.1186/s13071-023-06023-5 · Cited by 10
“In addition, activated microglia can directly engulf synapses, leading to synaptic loss [18–20].”
BackgroundLi, Z., Wu, J., Zhao, T., Wei, Y., Xu, Y., Liu, Z., Li, X., & Chen, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1296205 · Cited by 13
“One possible explanation is that an increase in C1q promotes the activation of C3, which is located downstream of the classical complement cascade and ultimately mediates synaptic phagocytosis via C3/CR3 signaling in microglia (Hong et al., 2016).”
BackgroundHao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 9
“Added to that, the activation of the complement system can induce the enhancement of microglia’s phagocytic function, potentially leading to inappropriate synaptic pruning (Hong et al., 2016).”
BackgroundChen, J., Wei, X., Wu, X.-F., Zhang, Q., Xia, G., Xia, H., Shang, H., & Lin, S. H. (2024) · Aging · doi:10.18632/aging.205960 · Cited by 12
Fasina, O. B., Li, L., Chen, D., Yi, M., Xiang, L., & Qi, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111719 · Cited by 9
“However, inappropriate activation of this pathway can lead to synapse loss in AD [25].”
BackgroundC1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain
Crowley, G., Kim, M., O’Neill, N., Turkes, E., Ghasemi, F., Giudice, L., Schepper, S. D., Tan, B. J. Y., Maffei, B., Ferreira, L. S. S., et al. (2026) · Science · doi:10.1126/science.adv1219 · Cited by 17
Self-citationCognitive disorders: Potential astrocyte-based mechanism
Li, S., Chen, Y., & Chen, G. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111181 · Cited by 12
Self-citationMa, X., Prokopenko, D., Wang, N., Aikawa, T., Choi, Y., Zhang, C. M., Lei, D., Ren, Y., Kawatani, K., Starling, S. C., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106813 · Cited by 10
“As eliminating microglia from the brain likely prevents neuronal loss in AD mouse models (Spangenberg et al., 2016), excessive microglial activation may induce deleterious effects (Brown and Neher, 2014; Hong et al., 2016).”
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li, W., Xie, Y., Jia-Xin, M., Shu-Chao, G., & Li-Ping, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149480 · Cited by 11
Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine
Karam, M., Ortega-Gascó, A., & Tornero, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073275 · Cited by 12
“Therefore, microglial activation following this cascade, and the resulting synapse loss, suggests that inflammatory pathways can act as early mediators of synapse loss and dysfunction that occur in AD models before plaques form [20].”
Du, X., Zhao, G., Fu, Y., Zhou, Y., Yang, L., Jiang, Z., Liu, S., Zhang, X., Zhu, K., Li, W., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163217 · Cited by 10
GADD45G operates as a pathological sensor orchestrating reactive gliosis and neurodegeneration
Shen, T., Tai, W., Jiang, D., Ma, S., Zhong, X., Zou, Y., & Zhang, C. (2025) · Neuron · doi:10.1016/j.neuron.2025.04.033 · Cited by 8
Arcos-Encarnación, B., Cortes-Flores, E., Barón-Mendoza, I., Almazán, J. L., Valle‐García, D., de León‐Guerrero, S. D., Hovan, L., Meza‐Sosa, K. F., Camacho‐Concha, N., Gil, J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03426-2 · Cited by 9
“These trimeric complex binds to C3R on microglia and astrocytes, leading to the phagocytosis of C1q-labeled neurons [76, 77].”
Interneuron transcriptomics reveals pathologic markers of Alzheimer's disease progression
Chen, K. S., Noureldein, M. H., Rigan, D. M., Hayes, J. M., Loi, K. J., Hur, J., Savelieff, M. G., & Feldman, E. L. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107012 · Cited by 11
“Complement C1q is elevated in AD and mediates, via microglia, early synaptic loss (Hong et al., 2016).”
Ogaki, A., Kinoshita, S., Ikegaya, Y., & Koyama, R. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03475-7 · Cited by 11
“Given that biogenic C3-tagged substrates are phagocytosed via complement receptor 3 (CR3), which is highly expressed in microglia [32, 33], we examined its role in non-bio-genic NP clearance.”
Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus
Lin, S. L., & Carroll, M. C. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102608 · Cited by 11
McGeachan, R. I., Ewbank, L., Watt, M., Sordo, L., Malbon, A. J., Salamat, M. K. F., Tzioras, M., Frias, J. M. D., Tulloch, J., Houston, F. E., et al. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70180 · Cited by 9
“Further, recent data link both microglia and astrocytes to synapse loss (Hong et al. 2016; Tzioras, Daniels, et al. 2023; Tzioras, McGeachan, et al. 2023), which is the strongest pathological correlate of cognitive decline (DeKosky and Scheff 1990; Terry et al. 1991; Scheff and Price 2006; Scheff…”
Yu, Y., Xiao, W., Ma, Z., Yi, X., Zhong, T., & Li, Z. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03528-x · Cited by 9
“…Brosselon et al. detected high C1q expression in the CSF of pre-dementia patients [40], while Hong et al. found significantly increased C1q levels in AD mouse models (J20 and APP/PS1 transgenic mice) even before extensive Aβ plaque deposition, implicating C1q in early neurodegenerative events [41].”
Pathological Mechanisms and Molecular Imaging Advances in Alzheimer’s Disease
Liu, C., Meng, Y., Liu, R., Wang, Z., & Zhao, H. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s534015 · Cited by 8
“38,39 Several immune cytokines, including tumor necrosis factor-α (TNF-α), interleukins (IL), and type I interferon, are closely linked to various AD processes.”
Xu, X., Tan, H., Yin, K., Xu, S., Wang, Z., Serrano, G. E., Beach, T. G., Wang, X., Peng, J., & Wu, R. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02455 · Cited by 11
Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations
Pawlak, A., Stefanowicz, J., Kotkowska, Z., Gabryelska, A., Sochal, M., Napieraj, F., Kotlicka‐Antczak, M., & Strzelecki, D. (2025) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2025.1656232 · Cited by 10
When sleep fails, brain clearance suffers: the role of glymphatic impairment in clinical neurology
la Herrán-Arita, A. K. D. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02959-w · Cited by 17
“1 A) [ 14–17].”
Weerakkody, T. N., Sabelström, H., Andrews, S. V., Chadarevian, J. P., Chin, M. Y., Tatarakis, D., Propson, N. E., Kim, D. J., Theolis, R., Parico, G. C. G., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw7428 · Cited by 13
The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist
Papavergi, M.-T., Bathini, P., Singh, B. B., & Lemere, C. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00916-y · Cited by 13
“Early synapse loss, preceding plaque formation, was documented in both J20 and APP/PS1 mice at 3–4 months of age, particularly within the CA1, CA3, and dentate gyrus regions [200].”
InfluentialSelf-citationZu, J., Li, C., Cui, M., Liu, X., Pan, Z., Li, X., Zhang, F., Gentz, J., Mitteregger-Kretzschmar, G., Herms, J. W., et al. (2025) · Brain · doi:10.1093/brain/awaf462 · Cited by 10
Behroozi, Z., Askarpour, H., & Baghcheghi, Y. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261415807 · Cited by 12
Yadav, A., Ouyang, X., Barkley, M., Watson, J. C., Madhamanchi, K., Kramer, J., Zhang, J., & Melkani, G. C. (2026) · Aging Cell · doi:10.1111/acel.70439 · Cited by 10
“Importantly, soluble Aβ oligomers, compared with insoluble aggregates, show a strong association with synapse loss and cognitive decline in AD patients (Hong et al. 2016; Shankar et al. 2008).”
Gandbhir, O., & Sundaram, P. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190107 · Cited by 8
Rahmani, N., Mohammadi, M., Manaheji, H. S., Maghsoudi, N., Katinger, H. W. D., Baniasadi, M., & Zaringhalam, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113576 · Cited by 8
Mehdipour, M., Emamghoreishi, M., Farrokhi, M. R., Fard, E. A., & Keshavarz, M. (2021) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2022.065 · Cited by 9
Wu, S., Miao, K., Wang, L., Ma, Y., & Wu, X. (2022) · Medical Oncology · doi:10.1007/s12032-022-01647-6 · Cited by 9
“The subtypes of C3 proteins (C3a and C3b) can strongly bind with many cell surface receptors to further activate downstream pathways, for example, C3b binding with complement receptor 1 (CR1 or CD35) to blockade the immune adherence [23] and binding with CD21 to promote the generation of B memory cell [24].”
BackgroundLiu, J., Zhang, C., Wang, J., Huang, Y., Shen, D., Hu, Y., Chu, H., Yu, X., Zhang, L., & Ma, H. (2022) · Pharmaceuticals · doi:10.3390/ph15121481 · Cited by 9
“Synaptic pathology might occur early in AD [6], and synaptic loss could precede neuronal degeneration [7].”
BackgroundLi, W., Pergande, M. R., Crutchfield, C. A., Searle, B. C., Backlund, P. S., Picache, J. A., Burkert, K. R., Yanjanin‐Farhat, N. M., Blank, P. S., Toth, C. L., et al. (2023) · PROTEOMICS · doi:10.1002/pmic.202200378 · Cited by 8
“disease the sameway as in other neurodegenerative diseases [45, 50].”
BackgroundHamza, E. A., Moustafa, A. A., Tindle, R., Karki, R., Nalla, S., Hamid, M. S., & Haj, M. E. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666230309113749 · Cited by 8
“Several studies suggest that cognitive decline and memory impairment in aging and AD is related to synaptic pruning [111-113].”
Ma, X., Yang, T., Liu, L., Peng, X., Qian, F., & Tang, F.-R. (2023) · Biomolecules · doi:10.3390/biom13050754 · Cited by 13
Park, K., Kim, R., Cho, K., Kong, C. H., Jeon, M., Kang, W. C., Jung, S. Y., Jang, D. S., & Ryu, J. H. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.08.002 · Cited by 9
“Expression levels of synaptophysin are decreased in AD patients [46] and AD animal models [47,48] with decreased synaptic plasticity [49].”
BackgroundCheng, Y., Chen, T., & Hu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-41066-9 · Cited by 9
Neutrophil-Mediated Progression of Mild Cognitive Impairment to Dementia
Cho, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914795 · Cited by 9
Zeng, R., Chen, J., Peng, Y., Xu, W., Tao, Y., Li, M., Zhang, R.-Q., Meng, J., Li, Z., Zeng, L., et al. (2023) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100591 · Cited by 8
“The number of colocalized spots was then divided by total area of the image stack (Wang et al., 2020a; Hong et al., 2016).”
Lu, L., Shi, Y., Wei, B., Li, W., Yu, X., Zhao, Y., Yu, D., & Sun, M. (2023) · iScience · doi:10.1016/j.isci.2023.108703 · Cited by 12
“57,58 In this study, we consistently found that synaptic function-related molecules SYN and PSD95 decreasedremarkably in the hippocampus of PH offspring through biological methods.”
MethodGlitches in the brain: the dangerous relationship between radiotherapy and brain fog
Marino, N., Bedeschi, M., Vaccari, M. E., Cambiaghi, M., & Tesei, A. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1328361 · Cited by 10
“Activated microglia are also observed in various neurodegenerative disorders, such as Alzheimer’s disease (AD) (Hong et al., 2016) and Parkinson’s disease (PD) (Lecours et al., 2018), where microglial activation contributed to aberrantly increased synaptic pruning.”
BackgroundGiatti, S., Cioffi, L., Diviccaro, S., Piazza, R., & Melcangi, R. C. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02345-y · Cited by 9
Davis, G. H., Zaya, A., & Pearce, M. M. P. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1256-23.2024 · Cited by 7
Emerging evidence of context-dependent synapse elimination by phagocytes in the CNS
Shen, F.-S., Liu, C., Sun, H.-Z., Chen, X., Xue, Y., & Chen, L. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae098 · Cited by 9
Broken strands, broken minds: Exploring the nexus of DNA damage and neurodegeneration
Stavgiannoudaki, I., Goulielmaki, E., & Garinis, G. A. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103699 · Cited by 8
Lizama, B. N., Williams, C., North, H. A., Pandey, K., Duong, D., Di Caro, V., Mecca, A. P., Blennow, K., Zetterberg, H., Levey, A. I., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14152 · Cited by 8
“54 Given that microglia can respond to and impact changes in synaptic activity, it is interesting to speculate whether there may be a non-cell-autonomous role of CT1812, thoughneuronalS2R,thatmayleadtoaneffectonmicrogliatofurther regulate synaptic activity and synaptic density.”
BackgroundKweon, B., Oh, J., Lim, Y., Noh, G., Yu, J., Kim, D., Jang, M., Kim, D., & Bae, G. (2024) · Nutrients · doi:10.3390/nu16223954 · Cited by 12
“In addition, microglia and immune signaling not only have limited roles such as in controlling the secreting inflammatory molecules in disease development but also modulate protein aggregation and synaptic loss in the early stages of neurodegeneration [24–26].”
Lapin, D., Sharma, A., & Wang, P. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03340-7 · Cited by 12
Hong, X., Chen, T., Liu, Y., Li, J., Huang, D., Ye, K., Liao, W., Wang, Y., Liu, M., & Luan, P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102669 · Cited by 10
Wohleb, E. S., Terwilliger, R. Z., Duman, C. H., & Duman, R. S. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1119 · Cited by 10
Thellung, S., Gatta, E., Pellistri, F., Villa, V., Corsaro, A., Nizzari, M., Robello, M., & Florio, T. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9749-2 · Cited by 9
Fujikawa, R., Higuchi, S., Nakatsuji, M., Yasui, M., Ikedo, T., Nagata, M., Hayashi, K., Yokode, M., & Minami, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.010 · Cited by 12
Arinuma, Y., & Yamaoka, K. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1791401 · Cited by 9
Chunchai, T., Keawtep, P., Arinno, A., Saiyasit, N., Prus, D., Apaijai, N., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00603-5 · Cited by 8
“Microglia contribute to synaptic modulation, and the cognitive process (Bocarsly et al. 2015), but one impact of the microglial hyperactivity associated with the Alzheimer’s model is the excessive pruning of synapses by the microglia (Hong et al. 2016; Kettenmann et al. 2013).”
BackgroundInfluentialRueda‐Carrasco, J., & Hong, S. Y. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.08.002 · Cited by 8
Self-citationAntiviral Immune Response in Alzheimer’s Disease: Connecting the Dots
Roy, E. R., & Cao, W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.577744 · Cited by 9
Insights into host-microbe interaction: What can we do for the swine industry?
Fan, L., Liu, B., Han, Z., & Ren, W. (2020) · Animal nutrition · doi:10.1016/j.aninu.2020.10.003 · Cited by 11
The roles of microglia in neural remodeling during retinal degeneration.
Gao, H., Huang, X., He, J., Zou, T., Chen, X., & Xu, H. (2022) · PubMed · doi:10.14670/hh-18-384 · Cited by 13
In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
Hall‐Roberts, H., Daniel, E. D., James, W., Davis, J. B., & Cowley, S. A. (2021) · Journal of Visualized Experiments · doi:10.3791/62217-v · Cited by 8
Magnetic resonance elastography to study the effect of amyloid plaque accumulation in a mouse model
Palotai, M., Schregel, K., Nazari, N., Merchant, J. P., Taylor, W. M., Guttmann, C. R. G., Sinkus, R., Young‐Pearse, T. L., & Patz, S. (2022) · Journal of Neuroimaging · doi:10.1111/jon.12996 · Cited by 10
Excessive local host-graft connectivity in aging and amyloid-loaded brain
Thomas, J. M., Martínez-Reza, M. F., Thorwirth, M., Zarb, Y., Conzelmann, K., Hauck, S. M., Grade, S., & Götz, M. (2022) · Science Advances · doi:10.1126/sciadv.abg9287 · Cited by 10
“Complement activation has a well-documented role in tagging synapses for elimination by microglia ( 56 , 67 , 68 ), a process that may be enhanced in these immune-activated environments ( 56 , 69 ).”
InfluentialCysteine string protein alpha accumulates with early pre-synaptic dysfunction in Alzheimer’s disease
Rupawala, H., Shah, K., Davies, C., Rose, J. L., Colom‐Cadena, M., Peng, X., Granat, L., Aljuhani, M., Mizuno, K., Troakes, C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac192 · Cited by 8
“Reactive astrocytes and microglia surround Aβ deposits(46) and phagocytose protein aggregates and degenerating synapses.(47,48) To determine if CSPalpha accumulates following the internalization of degenerating pre-synapses by glia, sections were co-labelled with antibodies against CSPalpha and either glial fibrillary…”
Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor
Morano, N. C., Smith, R. S., Danelon, V., Schreiner, R. P., Patel, U., Herrera, N. G., Smith, C., Olson, S. M., Lærke, M. K., Celikgil, A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157002 · Cited by 8
Tooth Loss Induces Memory Impairment and Glial Activation in Young Wild-Type Mice
Taslima, F., Abdelhamid, M., Zhou, C., Chen, Y., Jung, C., & Michikawa, M. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220053 · Cited by 8
Biundo, F., Chiţu, V., Tindi, J. O., Burghardt, N. S., Shlager, G. G. L., Ketchum, H. C., Deture, M. A., Dickson, D. W., Wszolek, Z. K., Khodakhah, K., et al. (2022) · Glia · doi:10.1002/glia.24310 · Cited by 10
“…the overexpression of C1q genes and attenuates C1q deposition on glutamatergic synapses in Csf1r+/ mice The complement cascade of the innate immune system has emerged as an important mediator of synapse pruning during both brain development and disease (Hong et al., 2016; Stevens et al., 2007).”
BackgroundPhadke, L., Lau, D. H. W., Aghaizu, N. D., Ibarra, S., Navarrón, C. M., Granat, L., Magno, L., Whiting, P. J., & Jolly, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1056067 · Cited by 9
“In many respects they mirror human biology closely, and the genes identified as being associated with inherited disease in humans are highly conserved in the rat genome (Huang et al., 2004).”
BackgroundWu, J., Xu, J. J., Naguib, M., & Bie, B. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03161-2 · Cited by 10
Carrillo, G. L., Su, J., Cawley, M. L., Wei, D., Gill, S. K., Blader, I. J., & Fox, M. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15770 · Cited by 17
“In animal models of Alzheimer's, where synapse loss is an early manifestation of the neurodegenerative process via the complement pathway, neuronal expression of complement C1q has been reported and linked to synapse elimination (Hong et al., 2016 ; Selkoe, 2002 ).”
Zatcepin, A., Kopczak, A., Holzgreve, A., Hein, S., Schindler, A., Duering, M., Kaiser, L., Lindner, S., Schidlowski, M., Bartenstein, P., et al. (2023) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2022.11.008 · Cited by 11
“Microglia, the brain resident innate immune cells, are an excellent target candidate for such a therapy, as these were shown to contribute to long-term neuronal repair after stroke [2], but also were linked to neurodegeneration and excessive synaptic pruning [3].”
BackgroundVerkhratsky, A., & Butt, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821565-4.00012-2 · Cited by 10
Cai, Y., Cui, T., Yin, P., Paganelli, P. M., Vicini, S., & Wang, T. (2023) · Aging Cell · doi:10.1111/acel.13989 · Cited by 8
“…extensive research, there is growing evidence underscoring the important function glial cells have in modulating synaptic transmission and plasticity, both under normal conditions and in the diseased brain (Chung et al., 2015; Hong et al., 2016; Keren-Shaul et al., 2017; Stogsdill & Eroglu, 2017).”
BackgroundContribution of resident and recruited macrophages in vascular physiology and pathology
Zhang, L. (2018) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000421 · Cited by 8
Nie, X., Wang, W., Wang, Q., Zhu, D., & Song, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9706 · Cited by 8
Neurophysiological alterations in the nucleus reuniens of a mouse model of Alzheimer's disease
Walsh, D. A., Brown, J. T., & Randall, A. D. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.006 · Cited by 9
Runge, E. M., Iyer, A. K., Setter, D. O., Kennedy, F. M., Sanders, V. M., & Jones, K. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01772-x · Cited by 8
Morrison, P. D., & Murray, R. M. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/pmorrison · Cited by 10
Nott, A., Holtman, I., Coufal, N., Schlachetzki, J., Yu, M., Hu, R., Han, C. Z., Pena, M., Xiao, J., Wu, Y., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/778183 · Cited by 11
“Additionally, the complement system has been implicated in microglia-mediated synaptic pruning in AD (80).”
Background
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.